Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company (ACH) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company (ACH) trades at $1.31 with AI Score 26/100 (Grade F). Accendra Health, Inc.
Price as of Aug 21, 2026 · Last analyzed: May 5, 2026ACH stock analysis for 2026: Analysts have set a consensus price target of $4.00 for Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company, suggesting 205.3% upside from the current price of $1.31. The AI MoonshotScore is 26/100, indicating a bearish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.
ACH: 2/3 scored disciplines lean bearish. Dominant signal: Izzy Englander bullish.
How is this calculated? →Why this analysis is different
- A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company (ACH) Healthcare & Pipeline Overview
Accendra Health, Inc. (ACH) delivers healthcare solutions through its Products & Healthcare Services and Patient Direct segments. The company provides medical supplies, equipment, and services to healthcare providers and in-home patients. Founded in 1882, Accendra Health serves multi-facility networks, independent hospitals, and physician practices, navigating a competitive healthcare distribution landscape.
What Is the Investment Thesis for ACH?
Accendra Health, Inc. (ACH) presents a complex investment case. The company's two-segment structure, Products & Healthcare Services and Patient Direct, offers diversification within the healthcare solutions market. However, the company's negative profit margin of -23.3% raises concerns about profitability. Key growth catalysts include expanding its proprietary product lines and enhancing its service offerings to healthcare providers. The company's beta of 1.29 suggests higher volatility compared to the market. Investors should closely monitor Accendra Health's ability to improve its financial performance and capitalize on growth opportunities in the healthcare sector. The company's rebranding in December 2025 may signal a strategic shift, but its long-term impact remains to be seen.
Based on FMP financials and quantitative analysis
ACH Key Highlights
Accendra Health operates in two segments: Products & Healthcare Services and Patient Direct, providing a diversified revenue stream.
- The company's gross margin stands at 31.0%, indicating a moderate level of profitability before operating expenses.
- Accendra Health serves a broad customer base, including multi-facility networks, independent hospitals, and physician practices.
- The company rebranded from Owens & Minor, Inc. to Accendra Health, Inc. in December 2025, potentially signaling a strategic shift.
- Accendra Health has a market capitalization of $100M, reflecting its current valuation in the market.
Who Are ACH's Competitors?
ACH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CAH Cardinal Health, Inc. | $231.00 | -1.64% | $54.1B | 90 |
| MCK McKesson Corporation | $853.71 | -1.79% | $100.0B | 90 |
| GEG Great Elm Group, Inc. | $2.15 | +0.00% | $67.4M | — |
| HX Akso Health Group | $2.24 | -4.27% | $53.4M | 38 |
| OMI Owens & Minor, Inc. | $2.68 | +8.94% | $207M | 44 |
| CQCQ MakingORG, Inc. | $0.75 | +0.00% | $26.7M | 61 |
| ZRSEF DocMorris AG | $10.24 | +0.00% | $500M | 41 |
| ARRJF Arjo AB (publ) | $2.91 | +0.00% | $793M | 43 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ACH's Key Strengths?
Diversified product and service offerings
- Established relationships with healthcare providers
- Direct-to-patient service capabilities
- Integrated supply chain solutions
What Are ACH's Weaknesses?
Negative profit margin
- High debt levels
- Dependence on key suppliers
- Intense competition
What Could Drive ACH Stock Higher?
Expansion of proprietary product lines to drive higher margins.
- Continued growth in the direct-to-patient segment due to increasing demand for in-home care.
- Strategic partnerships to expand market reach and product offerings.
What Are the Key Risks for ACH?
Financial-distress signal — its Altman Z-Score of 0.28 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Economic downturn impacting healthcare spending.
- Intense competition in the medical distribution industry.
- Regulatory changes affecting reimbursement rates and product approvals.
- Supply chain disruptions impacting product availability and costs.
What Are the Growth Opportunities for ACH?
- Expansion of Proprietary Product Lines: Accendra Health can drive growth by expanding its portfolio of proprietary medical and surgical supplies. Focusing on innovative, high-margin products can enhance profitability and differentiate the company from competitors. The market for proprietary medical devices is projected to grow at a CAGR of 6% over the next five years, presenting a significant opportunity for Accendra Health to increase its market share and revenue. Timeline: Ongoing.
- Enhancement of Healthcare Service Offerings: Accendra Health can enhance its service offerings to healthcare providers, including supplier management, analytics, and inventory management. By providing comprehensive solutions, the company can strengthen its relationships with customers and increase customer retention. The market for healthcare IT solutions is expected to reach $80 billion by 2028, indicating a growing demand for these services. Timeline: Ongoing.
- Geographic Expansion: Accendra Health can pursue geographic expansion to tap into new markets and diversify its revenue streams. Focusing on emerging markets with growing healthcare needs can provide significant growth opportunities. The healthcare market in Asia-Pacific is projected to grow at a CAGR of 8% over the next decade, making it an attractive region for expansion. Timeline: 2-3 years.
- Strategic Partnerships and Acquisitions: Accendra Health can pursue strategic partnerships and acquisitions to expand its product offerings and market reach. Collaborating with other companies in the healthcare industry can provide access to new technologies, products, and customers. The market for healthcare mergers and acquisitions is expected to remain active, presenting opportunities for Accendra Health to grow through inorganic means. Timeline: Ongoing.
- Direct-to-Patient Services Growth: Accendra Health can further develop its Patient Direct segment by expanding its offerings in diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. The increasing prevalence of chronic diseases and the growing demand for in-home care create a favorable environment for this segment. The global home healthcare market is projected to reach $400 billion by 2027, highlighting the growth potential for Accendra Health's direct-to-patient services. Timeline: Ongoing.
What Are ACH's Competitive Advantages?
- Established relationships with healthcare providers and suppliers
- Comprehensive portfolio of products and services
- Integrated supply chain solutions
- Direct-to-patient service capabilities
What Does ACH Do?
Founded in 1882 and based in Glen Allen, Virginia, Accendra Health, Inc. has evolved into a global healthcare solutions provider. Originally known as Owens & Minor, Inc., the company rebranded to Accendra Health, Inc. in December 2025, marking a strategic shift in its market approach. Accendra Health operates through two primary segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a comprehensive portfolio of medical and surgical supplies, including both branded and proprietary products. This segment also provides value-added services such as supplier management, analytics, inventory management, and clinical supply management to healthcare providers. Furthermore, it offers outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment focuses on delivering products and services for in-home care, addressing needs in diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment also supplies a range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence products. Accendra Health serves a diverse customer base, including multi-facility networks of healthcare providers, independent hospitals, surgery centers, and physicians' practices, both directly and indirectly through third-party distributors. The company's integrated approach aims to streamline healthcare supply chains and enhance patient care across various settings.
What Products and Services Does ACH Offer?
- Provides medical and surgical supplies to healthcare providers.
- Offers supplier management and analytics services to healthcare providers.
- Manages inventory and clinical supplies for hospitals and clinics.
- Provides outsourced logistics and marketing solutions to suppliers.
- Delivers products and services for in-home care, including diabetes treatment and respiratory therapy.
- Supplies home medical equipment and patient care products.
How Does ACH Make Money?
- Sells medical and surgical supplies to healthcare providers and distributors.
- Provides healthcare services, including supplier management and analytics.
- Offers direct-to-patient services for in-home care.
- Generates revenue through product sales and service fees.
What Industry Does ACH Operate In?
Accendra Health, Inc. operates within the medical distribution industry, a sector characterized by increasing demand for efficient supply chain solutions and patient care products. The industry is influenced by factors such as aging populations, technological advancements, and regulatory changes. Competition is intense, with companies vying for market share through product innovation, service enhancements, and strategic partnerships. Accendra Health's focus on both healthcare providers and direct-to-patient services positions it to capitalize on evolving market trends.
Who Are ACH's Key Customers?
- Multi-facility networks of healthcare providers
- Independent hospitals
- Surgery centers
- Physicians' practices
- Patients requiring in-home care
Company Profile
Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company operates in the Medical - Distribution industry within the Healthcare sector. It is headquartered in Glen Allen, US. The company is led by CEO Edward A. Pesicka. ACH has traded publicly since 1980.
Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company Financial Trajectory
Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company (ACH) reported $613.2M in revenue for Q2 2026, a decline of 2.3% compared to the prior quarter. The company recorded a net loss of $89.1M, with diluted EPS of $-1.16. Revenue has contracted over three consecutive quarters, which investors in this micro-cap Healthcare stock should monitor closely. Across the four most recent quarters, ACH averaged $-0.98 in diluted EPS.
How Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company Is Valued
Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company carries a market capitalization of $100M, placing it in the micro-cap category. Relative to its peer group, ACH's quantitative score of 26/100 is below the peer average of 66/100.
Key Financial Metrics
Return on equity for Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company stands at 264.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -44.8%, showing how much profit it generates from its asset base. Its free cash flow yield is -85.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.49 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 0.28 places it in the distress zone, a signal of elevated financial risk.
Forward Outlook
Wall Street analysts project Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company revenue of about $2.58B for fiscal 2026, with EPS near $0.41. The estimate reflects 4 contributing analysts.
ACH Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in ACH's future, indicating that leadership believes in the company's growth potential.
- Community sentiment has shifted positively, with discussions highlighting ACH's innovative healthcare solutions and their relevance in today's market.
- Analysts are noting an increase in demand for healthcare services, which could benefit ACH's business model and drive revenue growth.
- Recent partnerships with healthcare providers have positioned ACH favorably, enhancing its market presence and credibility.
Bear Case
- Concerns about potential regulatory changes in the healthcare sector have created uncertainty around ACH's operational stability.
- Social sentiment has shown some skepticism, with discussions around competition intensifying and concerns about ACH's market share.
- Insider selling has raised red flags for some investors, leading to worries about the company's short-term outlook.
- Recent product launches have received mixed reviews, suggesting that ACH may face challenges in gaining traction with its offerings.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $613M | -$89M | -$1.16 |
| Q1 2026 | $628M | -$6M | -$0.08 |
| Q4 2025 | $709M | -$56M | -$0.73 |
| Q3 2025 | $697M | -$150M | -$1.94 |
Based on FMP financials and quantitative analysis
ACH Latest News
-
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga · Aug 10, 2026
-
12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga · Aug 10, 2026
ACH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ACH.
Price Targets
Consensus target: $4.00
ACH MoonshotScore
What does this score mean?
The MoonshotScore rates ACH 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Latest Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company Analysis
Leadership: Edward A. Pesicka
CEO
Edward A. Pesicka serves as the Chief Executive Officer of Accendra Health, Inc., leading a workforce of 23,200 employees. His career spans various leadership roles within the healthcare and distribution industries. Prior to joining Accendra Health, Pesicka held executive positions at leading healthcare companies, where he focused on driving operational efficiency and strategic growth. He brings extensive experience in supply chain management, sales, and marketing. Pesicka's background includes a strong emphasis on customer-centric solutions and innovation within the healthcare sector.
Track Record: Since assuming the role of CEO, Edward A. Pesicka has focused on streamlining operations and improving financial performance. Key initiatives include optimizing the supply chain, expanding the company's proprietary product lines, and enhancing service offerings to healthcare providers. Under his leadership, Accendra Health has navigated a challenging market environment while focusing on long-term growth and value creation. The rebranding to Accendra Health, Inc. occurred under his leadership.
Common Questions About ACH (Healthcare)
What does the AI Score mean for ACH?
ACH holds an AI Score of 26/100 (Grade: F). This is an educational research signal, not a buy or sell recommendation. Accendra Health, Inc. is a healthcare solutions company providing products and services to healthcare providers and patients. The company operates through two segments: Products & Healthcare …
What does Accendra Health, Inc. do?
Accendra Health, Inc. operates as a healthcare solutions company, providing a range of products and services to healthcare providers and patients. The company's two segments, Products & Healthcare Services and Patient Direct, offer medical and surgical supplies, equipment, and related services. Accendra Health serves multi-facility networks, independent hospitals, surgery centers, and physician practices, as well as patients requiring in-home care.
What do analysts say about ACH stock?
Analyst coverage of Accendra Health, Inc. (ACH) is limited, reflecting its market capitalization of $100M. Key valuation metrics, such as price-to-earnings and price-to-sales ratios, are difficult to assess due to the company's negative profit margin of -23.3%. Growth considerations include the company's ability to expand its proprietary product lines and enhance its service offerings.
What are the main risks for ACH?
Accendra Health, Inc. faces several risks, including intense competition in the medical distribution industry, economic downturn impacting healthcare spending, regulatory changes affecting reimbursement rates and product approvals, and supply chain disruptions impacting product availability and costs. The company's negative profit margin also poses a significant risk, as it raises concerns about its financial sustainability. Investors should carefully consider these risks before investing in Accendra Health.
What are the key factors to evaluate for ACH?
Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company (ACH) holds an AI score of 26/100 (low). Analysts target $4.00 (+205%). Not financial advice.
How frequently does ACH data refresh on this page?
ACH's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven ACH's recent stock price performance?
Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company (ACH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified product and service offerings. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ACH overvalued or undervalued right now?
Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company (ACH) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Analysts target $4.00 (+205%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research ACH before investing?
Before investing in Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company (ACH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- Analyst opinions may vary.
- This is a research platform, not investment advice. Conduct your own due diligence.